Welcome

PharmaSea brings together a broad international, interdisciplinary consortium of 24 partners from 13 countries from industry, academia and non-profit organisations with world-leading researchers in the areas of marine genomics, biosynthesis and chemical structure analysis as well as legal experts. The PharmaSea project focuses on biodiscovery research and the development and commercialisation of new substances from marine organisms. Its primary goal is to collect samples from some of the hottest, deepest and coldest places on the planet. These samples will be screened to uncover marine microbes and new bioactive compounds to evaluate their potential as novel drug leads, antibiotics or ingredients for nutrition or cosmetic applications. PharmaSea is funded by the European Union under its FP7 programme.

News

  • Video on biodiversity, bioinformatics and biotechnology

    Video on biodiversity, bioinformatics and biotechnology

    14.11.2016 - A documentary film on the hidden biological treasures of the ocean by MicroB3. More

  • UN agrees to fight 'the biggest threat to modern medicine': antibiotic resistance

    UN agrees to fight 'the biggest threat to modern medicine': antibiotic resistance

    21.09.2016 - All 193 United Nations member states are set to sign a declaration agreeing to combat “the biggest threat to modern medicine” in Wednesday’s high-level meeting on antibiotic resistance. More

  • Medicine from the oceans

    Medicine from the oceans

    11.07.2016 - The sea is full of microorganisms, microscopically small creatures such as bacteria, algae or fungi. Despite these potentials and the fact that the deep sea is one of the largest ecosystems in the world, only a small part of the marine biodiversity has been discovered. Projects such as MaCuMBA or PharmaSea strive to improve this state of knowledge. More

Executive Committee

Institutions

Calendar

All events